6-K 1 dp68092_6k.htm FORM 6-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August, 2016

 

 

 

Commission File Number: 001-13742

 

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

 

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

X 

 

Form 40-F

 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes

 

 

No

X 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes

 

 

No

X

 

 





 

ISRAEL CHEMICALS LTD.

 

 INCORPORATION BY REFERENCE

 

This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 





 

ISRAEL CHEMICALS LTD.

 

 

1.

Allana Afar Tax Assessment

 

 

 




 

Item 1

 

August 23, 2016

 

 

Allana Afar Tax Assessment

 

Further to Note 8 of ICL's (the "Company") financial statements for the second quarter of 2016, the Company hereby reports that the Review Committee of the Ethiopian Tax Authority has rejected Allana Afar's appeal and validated the tax assessment in the amount of about $55 million. As at June 30, 2016, the Company has booked a provision in the amount of $27 million as part of the acquisition cost. The Company is contemplating the range of possible actions.

 

 





 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

Israel Chemicals Ltd.

 

 

 

 

 

 

By:

/s/ Kobi Altman

 

 

 

 

Name:

Kobi Altman

 

 

 

 

Title:

Chief Financial Officer

 

 

 

Israel Chemicals Ltd.

 

 

 

 

 

 

By:

/s/ Lisa Haimovitz

 

 

 

 

Name:

Lisa Haimovitz

 

 

 

 

Title:

Senior Vice President, Global General Counsel and Corporate Secretary

 

Date: August 23, 2016